Benefit of Adjuvant Chemotherapy in Patients with ctDNA-positive Resected Stage II Colon Cancer By Ogkologos - July 30, 2026 108 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CIRCULATE, an AIO (KRK-0217)/ABCSG study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Relacorilant Annual Multicancer Early Detection Test Not Associated with a Lower Incidence Rate of Stage III or IV Cancer After Three Screening Rounds and 12... ESMO welcomes the adoption of European Parliament Report on Europe’s Beating Cancer Plan in the Committee on Public Health (SANT), calls for further EU... MOST POPULAR Metronomic Capecitabine as Adjuvant Therapy Provides Compelling Evidence In Locoregionally Advanced... June 14, 2021 How My Cancer Diagnosis at Age 17 Changed My Perspective on... December 14, 2020 EMA Adopts a Positive Opinion for Dabrafenib for the Treatment of... September 25, 2023 A bug in the system – the difficulties of linking the... June 2, 2021 Load more HOT NEWS Glioblastoma Study Highlights Sex Differences in Brain Cancer Safety, Tolerability and Antitumour Activity of Lorlatinib in Patients with ALK-Driven... Picture Showing A Realistic View Of A Woman’s Milk Ducts Goes... No Link Between Caffeine Consumption and Breast Cancer, Study Finds
